Jeff Yass’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $898K | Buy |
31,500
+11,200
| +55% | +$244K | ﹤0.01% | 8461 |
|
|
2026
Q1 | $352K | Buy |
+20,300
| New | +$384K | ﹤0.01% | 10513 |
|
|
2025
Q4 | – | Sell |
-18,400
| Closed | -$268K | – | 12436 |
|
|
2025
Q3 | $268K | Sell |
18,400
-13,500
| -42% | -$192K | ﹤0.01% | 10380 |
|
|
2025
Q2 | $623K | Buy |
31,900
+17,800
| +126% | +$316K | ﹤0.01% | 8658 |
|
|
2025
Q1 | $250K | Buy |
14,100
+1,600
| +13% | +$34.5K | ﹤0.01% | 10472 |
|
|
2024
Q4 | $268K | Sell |
12,500
-38,000
| -75% | -$924K | ﹤0.01% | 10077 |
|
|
2024
Q3 | $1.58M | Buy |
50,500
+13,700
| +37% | +$341K | ﹤0.01% | 5789 |
|
|
2024
Q2 | $572K | Sell |
36,800
-39,100
| -52% | -$473K | ﹤0.01% | 7937 |
|
|
2024
Q1 | $804K | Buy |
75,900
+58,000
| +324% | +$580K | ﹤0.01% | 7398 |
|
|
2023
Q4 | $215K | Buy |
+17,900
| New | +$147K | ﹤0.01% | 10532 |
|
|
2023
Q3 | – | Sell |
-10,200
| Closed | -$86.7K | – | 12073 |
|
|
2023
Q2 | $86.7K | Sell |
10,200
-14,400
| -59% | -$120K | ﹤0.01% | 11054 |
|
|
2023
Q1 | $225K | Buy |
+24,600
| New | +$315K | ﹤0.01% | 10343 |
|
|
2022
Q4 | – | Sell |
-14,000
| Closed | -$238K | – | 12502 |
|
|
2022
Q3 | $238K | Sell |
14,000
-8,400
| -38% | -$180K | ﹤0.01% | 10402 |
|
|
2022
Q2 | $481K | Sell |
22,400
-25,900
| -54% | -$718K | ﹤0.01% | 8355 |
|
|
2022
Q1 | $1.79M | Buy |
48,300
+7,600
| +19% | +$296K | ﹤0.01% | 5728 |
|
|
2021
Q4 | $1.85M | Sell |
40,700
-1,100
| -3% | -$57.4K | ﹤0.01% | 5695 |
|
|
2021
Q3 | $2.65M | Sell |
41,800
-193,800
| -82% | -$14.8M | ﹤0.01% | 5224 |
|
|
2021
Q2 | $21.6M | Buy |
235,600
+139,000
| +144% | +$11M | ﹤0.01% | 1933 |
|
|
2021
Q1 | $6.58M | Buy |
96,600
+26,900
| +39% | +$2.09M | ﹤0.01% | 3427 |
|
|
2020
Q4 | $5.05M | Sell |
69,700
-59,800
| -46% | -$3.46M | ﹤0.01% | 3402 |
|
|
2020
Q3 | $4.91M | Buy |
129,500
+27,600
| +27% | +$932K | ﹤0.01% | 3072 |
|
|
2020
Q2 | $3.61M | Buy |
101,900
+42,500
| +72% | +$1.21M | ﹤0.01% | 3495 |
|
|
2020
Q1 | $1.3M | Buy |
59,400
+28,300
| +91% | +$634K | ﹤0.01% | 4784 |
|
|
2019
Q4 | $671K | Sell |
31,100
-17,700
| -36% | -$406K | ﹤0.01% | 6346 |
|
|
2019
Q3 | $1.1M | Sell |
48,800
-115,200
| -70% | -$3.19M | ﹤0.01% | 5492 |
|
|
2019
Q2 | $5.9M | Sell |
164,000
-20,500
| -11% | -$656K | ﹤0.01% | 2495 |
|
|
2019
Q1 | $5.82M | Buy |
184,500
+138,200
| +298% | +$4.03M | ﹤0.01% | 2293 |
|
|
2018
Q4 | $1.16M | Buy |
46,300
+10,000
| +28% | +$257K | ﹤0.01% | 4396 |
|
|
2018
Q3 | $1.05M | Buy |
+36,300
| New | +$679K | ﹤0.01% | 5132 |
|
Other funds holding CDNA
DM
AIM
GS
Jeff Yass's CDNA Position: Q2 2026 in Review
Jeff Yass reduced its CareDx (CDNA) stake by 32% in Q2 2026, selling an estimated $349K and leaving 34,601 shares worth $986K. The position accounts for ﹤0.01% of the portfolio, ranked #8233.
Jeff Yass first reported a position in CDNA in Q1 2018 and has held it in 30 quarters since. The position peaked at $4.52M in Q4 2020. 226 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Jeff Yass held 34,601 shares of CareDx worth $986K as of Q2 2026.
- Jeff Yass sold 16,045 CareDx shares in Q2 2026, an estimated $349K.
- CareDx made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8233 holding.
- Jeff Yass first reported a position in CareDx in Q1 2018 and has held it in 30 quarters since.
- Jeff Yass's CareDx position peaked at $4.52M in Q4 2020.
- 226 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.